Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.
Why Fear Level Among US Investors Is Decreasing
The CNN Money Fear and Greed index showed further decline in the fear level among US investors as stocks recorded gains for a second straight session.
Concerns over recession and aggressive rate-hikes by major central banks have pushed the Wall Street to their lows of the year recently. However, US markets moved higher this week amid strong start to the earnings season.
